HIV

At the Forefront of HIV Health and Healing in Spain: Ferran's Story

Blog

As the founder and director of BCN Checkpoint, a community HIV program geared toward gay men and transgender women in Barcelona, Ferran Pujol has helped provide hope to those living with HIV for nearly 30 years. But for Ferran, the healing he has brought to thousands of others began in a much darker place for him.

In 1986, he fell into a deep depression after both he and his partner, Michael, were diagnosed with HIV. With few effective treatments at the time, the news terrified him.

How This HIV Activist Prioritizes Wellness in His Day-to-Day

Paris Mullen shares why it's so important to make self-care a daily habit
Blog

This past year has been challenging for everyone, and isolation and the continued strain of remote work and school have put a spotlight on the importance of personal wellbeing. For Paris Mullen, a Merck community liaison and HIV activist, the pandemic is a reminder to be more intentional with self-care. And while he admits that prioritizing this can be difficult, he’s trying his best.

Ending HIV-Related Stigma in the Southern United States: Gina's Story

Blog

Gina Brown has been living with HIV for 27 years and introduces herself as a social worker by training, but an activist by birth. As the Director of Strategic Partnerships and Community Engagement at the Southern AIDS Coalition, she’s working to fight against challenges that she has personally experienced such as homelessness, addiction and abuse, as well as stigma, racism, sexism and ageism.

HIV in the Time of COVID-19: The Case for Investment

Multimedia with summary

As the world continues to grapple with COVID-19, we can’t lose sight of another health crisis: the ongoing HIV epidemic. In this Gilead-created policy paper, read about the critical role that continued investment in HIV can play in supporting public health and achieving our shared goal of ending the epidemic by 2030.

Improving HIV Care With Telehealth

Multimedia with summary

Telehealth has transformed HIV service delivery during the COVID-19 pandemic. But as a new Gilead policy paper explains, it’s critical that telehealth programs are designed to promote health equity and include all populations, including low-income individuals, people in non-urban areas with less technology access and older populations with low technology or health literacy. Learn more.

Leveraging Mobile Technology & Creative Storytelling to Enhance HIV Prevention, Care and Treatment for Children and Adolescents

Article

Great strides have been made in the fight against HIV and AIDS globally. This is especially true in South Africa, which has the world’s largest HIV treatment program. However, largely due to social and structural barriers, children and adolescents are still being left behind. The KidzAlive Mobilized program aims to help fill the gap.

Broader Access is Vital to the Future of Testing and Healthcare Innovation

Summary: 

Building on lessons learned from the COVID-19 pandemic, there are significant opportunities to expand the use of rapid testing to address many health challenges around the world- from infectious diseases like malaria and HIV to non-infectious health needs like prenatal care. Learn how Abbott is intentionally approaching product development to democratize, decentralize and digitize testing to help more people live healthier lives.

Article

Building on lessons learned from the COVID-19 pandemic, there are significant opportunities to expand the use of rapid testing to address many health challenges around the world- from infectious diseases like malaria and HIV to non-infectious health needs like prenatal care. Learn how Abbott is intentionally approaching product development to democratize, decentralize and digitize testing to help more people live healthier lives.

CNH Industrial Thailand Supports Local HIV Charity

Blog

CNH Industrial Thailand mobilized its employees and collected donations to support the Thammarak Foundation, which is focused on providing care for HIV positive patients in Thailand.

Abbott Researchers Find Rare Group of People With Controlled HIV Who Could Be a Key to Unlocking Cure

Summary: 
  • Study of more than 10,000 people identifies a rare group with controlled HIV in the Democratic Republic of Congo, suggesting additional research could uncover links between natural virus suppression and future treatments
  • Discovery is a result of Abbott's continued virus hunting efforts, which also uncovered a new strain of HIV in 2019
  • Abbott's decades of work in global viral surveillance has advanced the understanding of HIV and allowed the company to quickly respond to the COVID-19 pandemic with its diagnostic tests
Press Release
  • Study of more than 10,000 people identifies a rare group with controlled HIV in the Democratic Republic of Congo, suggesting additional research could uncover links between natural virus suppression and future treatments
  • Discovery is a result of Abbott's continued virus hunting efforts, which also uncovered a new strain of HIV in 2019
  • Abbott's decades of work in global viral surveillance has advanced the understanding of HIV and allowed the company to quickly respond to the COVID-19 pandemic with its diagnostic tests

Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the Imbokodo Study

The clinical trial has completed full immunizations of the company's investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.
Blog

Since the start of the pandemic, Johnson & Johnson has been working to help address the devastating impacts of COVID-19 through the power of its science, the size of its global reach—and the know-how that comes from such experiences as standing up to challenges like HIV.

Pages

Subscribe to HIV